Kala Y. Kamdar, MD

Location

  • Texas Medical Center

Specialty

Cancer
Blood Disorders

Phone: 832-824-4163
Fax: 832-825-4732

Contact Information

6701 Fannin St., Ste. 1510.17
Houston, TX 77030
United States
Texas

Research Area

  • Epidemiology
  • Lymphoma

Associate Director, Clinical Division (Outpatient), Cancer and Hematology Centers
Co-Director, Lymphoma Program
Associate Director, Pediatric Lymphoma-Histiocytosis Fellowship Program
Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine

Education

School Education Degree Year
University of Texas School of Public Health masters Master of Science, Epidemiology 2010
University of Texas M. D. Anderson Cancer Center post-doctoral fellow Cancer Prevention 2008
Baylor College of Medicine fellowship Pediatric Hematology-Oncology 2008
University of Cincinnati / Cincinnati Children’s Hospital Medical Center residency Internal Medicine/Pediatrics 2005
University of Cincinnati College of Medicine internship Internal Medicine/Pediatrics 2001
University of Louisville School of Medicine medical school Doctor of Medicine 2000
University of Louisville bachelors Bachelor of Science, Chemical Engineering 1996

About

Board Certifications
American Board of Pediatrics
American Board of Pediatrics – Hematology/Oncology
American Board of Internal Medicine

Organization

Organization Name Role
American Academy of Pediatrics (AAP) Member
American Association for Cancer Research (AACR) Member
American Society for Pediatric Hematology/Oncology (ASPHO) Member

Research Statement

Dr. Kala Kamdar's principal research interest is in the prevention of long-term complications of childhood cancer therapies. Due to the need for cancer therapies at a young age, adult survivors of childhood cancer face unique long-term health problems, including neurocognitive impairment and learning difficulties.

Using a molecular epidemiology approach, Dr. Kamdar's current research is focused on genetic susceptibility to neuropsychological impairment after acute lymphoblastic leukemia therapy. Specifically, she is investigating the role of genetic polymorphisms in the folate pathway and the xenobiotic detoxification pathway on the development of neurocognitive impairment after exposure to methotrexate chemotherapy, a folate analog.

Ultimately, identification of children at risk for long-term toxicities may lead to modification of treatment regimens or other interventions to minimize these long-term toxicities.

Her research interests include: 1) the long-term complications of childhood cancer therapy, 2) molecular epidemiology, 3) genetic susceptibility to neuropsychological impairment, 4) exposure to methotrexate chemotherapy, and 5) the risk for long-term toxicities.

Awards

2015 - Present    Fulbright & Jaworski L.L.P. Faculty Excellence Award

2013 - Present    Texas Children’s Cancer and Hematology Center Faculty Recognition Award

2008 - Present    AACR-WICR Brigid G. Leventhal Scholar Award, American Association for Cancer Research, Annual Meeting

2008 - Present    Bone Marrow Transplant Fellow Oral Presentation Award, Baylor College of Medicine

2007 - Present    Selected for participation in American Association for Cancer Research Molecular Biology in Clinical Oncology Workshop, Aspen CO

2007 - Present    Russell and Virginia McFarland Award for Oral Presentation of Research, Pediatric Grand Rounds, Texas Children’s Hospital

2007 - Present    Participant, National Institute of Environmental Health Sciences SNP Workshop, Galveston, TX 

2006 - Present    Best Tumor Board Award, Texas Children’s Cancer Center and Hematology Services, Baylor College of Medicine

2005 - Present    Vale-Asche Foundation Fellowship

2004 - Present    The Doctor’s Doctor Award, Department of Internal Medicine, University of Cincinnati

2004 - Present    Duke University Evidence-Based Medicine Workshop, Duke University , Durham, NC,

2003 - Present    2nd Place Poster, American College of Physicians Ohio Chapter Scientific Meeting

1999 - Present    Alpha Omega Alpha Honor Medical Society

1995 - Present    Donald F. Othmer Academic Excellence Award, American Institute of Chemical Engineers